It was reported that there is singular importance of blocking Tim-3 on DCs, but not on T or other immune cells, promoting strong anti-tumor immunity 18 and making Tim-3 on DCs a novel checkpoint for immunotherapy. Here, HAVCR2 is linked to neoplasm.